SCHEMBL29466288

SCHEMBL29466288

O=C(c1cccc(-c2nc3ccccc3[nH]2)n1)N1CCC2(CCNCC2)CC1

nearest known ligand 0.79

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LANCL2 Q9NS86 1/20 0.79
GABRD O14764 3/20 0.46
GABRA1 P14867 3/20 0.46
GABRB1 P18505 3/20 0.46
GABRA5 P31644 3/20 0.46
GABRA3 P34903 3/20 0.46
GABRA2 P47869 3/20 0.46
GABRB2 P47870 3/20 0.46
GABRA4 P48169 3/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
ATR Q13535 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
HRH4 Q9H3N8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25314181 1.00 LANCL2 (0.79) LANCL2GABRDGABRA1GABRB1GABRA5
SCHEMBL25877375 0.96 LANCL2 (0.86) LANCL2MEN1KMT2AATRHRH4
SCHEMBL29466338 0.96 LANCL2 (0.86) LANCL2MEN1KMT2AATRHRH4
SCHEMBL25881551 0.95 LANCL2 (0.74) LANCL2GABRDGABRA1GABRB1GABRA5
SCHEMBL25881624 0.92 LANCL2 (0.69) LANCL2GABRDGABRA1GABRB1GABRA5
SCHEMBL25312093 0.91 LANCL2 (0.79) LANCL2MEN1KMT2AATRCYP1A2
SCHEMBL25877794 0.91 LANCL2 (0.82) LANCL2MEN1KMT2AATRHRH4
SCHEMBL17705594 0.90 LANCL2 (0.88) LANCL2MEN1KMT2AATRHRH4
SCHEMBL25879755 0.89 LANCL2 (0.76) LANCL2MEN1KMT2AATRHRH4
SCHEMBL25881745 0.89 LANCL2 (0.71) LANCL2MEN1KMT2AATRHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114195780-A Carbonyl heterocyclic compound and application thereof 上海医药集团股份有限公司 2022-03-18 CN disclosed
CN-114195806-A Carbonyl heterocyclic compound and application thereof 上海医药集团股份有限公司 2022-03-18 CN disclosed